Medtech
J&J is balking at a plan to build a site in Britain due to concerns over the economy.
A look at the FDA’s long-awaited guidelines on how it will regulate regenerative medicine products, including stem cells.
Qiagen’s investment will be an expansion of its current operations in that northern England city.
The former Globus engineer took the new job at Stryker earlier this month.
Eli Lilly continues to make investments in its diabetes business.
The agreement, whose final terms are still being negotiated, must be approved by a court.
Fresenius Kabi will invest $100M in eastern North Carolina as it expands its current production facility and prepares to build a new onsite manufacturing center.
A look at the 19 spine-related medical devices the FDA cleared in October.
Over the years, Intuitive Surgical has carved out a place for itself as one of the few providers of minimally-invasive, robotically-assisted surgical equipment.
The company is expected to face growing competition from Abbott and Boston Scientific in heart implants, an analyst said.
PRESS RELEASES